Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies : An UNLOCK Validation Study
Annemarije L Kruis,Björn Ställberg,Rupert Jones,Ioanna Tsiligianni,Karin Lisspers,Thys van der Molen,Janwillem W. H. Kocks,Niels H. Chavannes +7 more
Reads0
Chats0
TLDR
Primary care COPD patients stand out from patients enrolled in LPCS in terms of gender, lung function, quality of life and exacerbations, as hitherto unknown GOLD I exacerbation characteristics are revealed.Abstract:
Background: Guideline recommendations for chronic obstructive pulmonary disease (COPD) are based on the results of large pharmaceutically-sponsored COPD studies (LPCS). There is a paucity of data on disease characteristics at the primary care level, while the majority of COPD patients are treated in primary care. Objective: We aimed to evaluate the external validity of six LPCS (ISOLDE, TRISTAN, TORCH, UPLIFT, ECLIPSE, POET-COPD) on which current guidelines are based, in relation to primary care COPD patients, in order to inform future clinical practice guidelines and trials. Methods: Baseline data of seven primary care databases (n = 3508) from Europe were compared to baseline data of the LPCS. In addition, we examined the proportion of primary care patients eligible to participate in the LPCS, based on inclusion criteria. Results: Overall, patients included in the LPCS were younger (mean difference (MD)-2.4; p = 0.03), predominantly male (MD 12.4; p = 0.1) with worse lung function (FEV1% MD -16.4; p = 1 and >= 2 exacerbations, although results were not statistically significant. Our findings add to the literature, as we revealed hitherto unknown GOLD I exacerbation characteristics, showing 34% of mild patients had >= 1 exacerbations per year and 12% had >= 2 exacerbations per year. The proportion of primary care patients eligible for inclusion in LPCS ranged from 17% (TRISTAN) to 42% (ECLIPSE, UPLIFT). Conclusion: Primary care COPD patients stand out from patients enrolled in LPCS in terms of gender, lung function, quality of life and exacerbations. More research is needed to determine the effect of pharmacological treatment in mild to moderate patients. We encourage future guideline makers to involve primary care populations in their recommendations.read more
Citations
More filters
Journal ArticleDOI
Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD
Janine A M Westerik,Esther Metting,Job F M van Boven,Waling Tiersma,Janwillem W. H. Kocks,Tjard Schermer +5 more
TL;DR: Having another chronic respiratory disease beside COPD showed the highest risk for developing a new exacerbation and several chronic comorbidities were associated with having frequent exacerbations and increased exacerbation risk.
Journal ArticleDOI
Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units.
Josefin Sundh,Gunnar Johansson,Kjell Larsson,Anders Lindén,Claes-Göran Löfdahl,Christer Janson,Thomas Sandström +6 more
TL;DR: It is concluded that comorbid conditions, in particular chronic bronchitis, depression, osteoporosis, and musculoskeletal symptoms, should be taken into account in the clinical management of patients with severe COPD.
Journal ArticleDOI
Improving the Management of COPD in Women.
Christine Jenkins,Kenneth R. Chapman,James F. Donohue,Nicolas Roche,Ioanna Tsiligianni,MeiLan K. Han +5 more
TL;DR: A multifaceted approach is required to address COPD in women, including greater awareness, minimization of risk, and further elucidation of the sex-specific factors that affect risk, disease progression, and treatment success.
Journal ArticleDOI
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective
MeiLan K. Han,Carlos H. Martinez,David H. Au,David H. Au,Jean Bourbeau,Cynthia M. Boyd,Richard D. Branson,Gerard J. Criner,Ravi Kalhan,Thomas J Kallstrom,Angela King,Jerry A. Krishnan,Suzanne C. Lareau,Todd A. Lee,Kathleen O. Lindell,David M. Mannino,Fernando J. Martinez,Catherine A. Meldrum,Valerie G. Press,Byron Thomashow,Laura Tycon,Jamie L. Sullivan,John MacLaren Walsh,Kevin C. Wilson,Kevin C. Wilson,Jean Wright,Barbara P. Yawn,Patrick M. Zueger,Surya P. Bhatt,Mark T. Dransfield,Mark T. Dransfield +30 more
TL;DR: This Commission summarises expert opinion from key stakeholders-patients, caregivers, and medical professionals, as well as representatives from health systems, insurance companies, and industry-to understand barriers to care delivery and propose potential solutions.
Journal ArticleDOI
Predicting frequent COPD exacerbations using primary care data
TL;DR: Patients at risk of exacerbation can be identified from routinely available, computerized primary care data and a robust, clinically based model to predict frequent exacerbation risk was developed.
References
More filters
Journal ArticleDOI
Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.
TL;DR: The IT system used in this study has the potential to improve diagnosis and management of COPD in primary care and should be used for post bronchodilator readings for diagnosis.
Journal ArticleDOI
Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial
Niels H. Chavannes,Marlous Grijsen,Marjan van den Akker,Huub Schepers,Maddy Nijdam,Brian Tiep,Jean W M Muris +6 more
TL;DR: In this study, IDM improved one-year quality of life in primary care COPD patients, compared to usual care, and was greatest in patients with FEV1/FVC <0.7 and MRC Dyspnoea score >2.
Journal ArticleDOI
The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD
Josefin Sundh,Christer Janson,Karin Lisspers,Björn Ställberg,Scott Montgomery,Scott Montgomery +5 more
TL;DR: The DOSE index is associated with mortality in COPD patients in primary and secondary care and can be used to assess prognosis in addition to other clinically relevant issues.
Journal ArticleDOI
Use of spirometry and patterns of prescribing in COPD in primary care
Marc Miravitlles,Cristian de la Roza,Karlos Naberan,Maite Lamban,Elena Gobartt,Antonio Martín +5 more
TL;DR: Important deficiencies were observed in the interpretation of the results of spirometry and these difficulties may influence the low implementation of treatment guidelines in COPD in PC.
Journal ArticleDOI
Controversies in treatment of chronic obstructive pulmonary disease.
TL;DR: Novel therapeutic drugs are urgently needed for optimum management of the acute COPD exacerbation and more relevant diagnostic methods are needed that can be used to describe COPD severity and comorbidity.